AstraZeneca and Takeda Chemical promote Atacan's landmark clinical trials
The DIRECT Programme, conducted and jointly sponsored by AstraZeneca and Takeda Chemical Ind., is the first Programme designed to establish whether treatment with a...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
